- Home
- Automated
- List of product information
- BETNOVATE CREAM 0.1% W/W [SIN08247P]
BETNOVATE CREAM 0.1% W/W [SIN08247P]
Active ingredients: BETNOVATE CREAM 0.1% W/W
Last updated 26 October 2025
Product Info
BETNOVATE CREAM 0.1% W/W
[SIN08247P]
Product information
Active Ingredient and Strength | BETAMETHASONE VALERATE EQV BETAMETHASONE - 0.1% W/W |
Dosage Form | CREAM |
Manufacturer and Country | GLAXO WELLCOME OPERATIONS - UNITED KINGDOM |
Registration Number | SIN08247P |
Licence Holder | GLAXOSMITHKLINE PTE LTD |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | D07AC01 |
INDICATIONS
Eczema including atopic, infantile, and discoid eczemas.
Prurigo nodularis.
Psoriasis (excluding widespread plaque psoriasis).
Neurodermatoses including lichen simplex, lichen planus.
Seborrhoeic dermatitis.
Contact sensitivity reactions.
Discoid lupus erythematosus.
An adjunct to systemic steroid therapy in generalised erythroderma.
Insect bite reactions.
Prickly heat.
DOSAGE AND ADMINISTRATION
A small quantity should be applied to the affected area two or three times daily until improvement occurs. It may then be possible to maintain improvement by applying once a day, or even less often.
Betnovate creams are especially appropriate for moist or weeping surfaces and Betnovate ointments for dry, lichenified or scaly lesions, but this is not invariably so.
In the more resistant lesions, such as the thickened plaques of psoriasis on elbows and knees, the effect of Betnovate can be enhanced, if necessary, by occluding the treatment area with polythene film. Overnight occlusion only is usually adequate to bring about a satisfactory response in such lesions thereafter, improvement can usually be maintained by regular application without occlusion.
CONTRA-INDICATIONS
Rosacea.
Acne vulgaris.
Perioral dermatitis.
Perianal and genital pruritus.
Primary cutaneous viral infections (e.g. herpes simplex, chickenpox).
Hypersensitivity to the preparations.
The use of Betnovate skin preparations is not indicated in the treatment of primarily infected skin lesions caused by infection with fungi or bacteria, dermatoses in children under one year of age, including dermatitis and napkin eruptions.